Format

Send to

Choose Destination
Expert Rev Cardiovasc Ther. 2013 Aug;11(8):985-97. doi: 10.1586/14779072.2013.814839. Epub 2013 Aug 16.

Lipid-lowing pharmacogenomics in Chinese patients.

Author information

1
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong SAR.

Abstract

Pharmacogenomic studies on statins ranging from the candidate gene approach to the genome-wide studies in western populations have provided evidence that genetic variations play a limited role in determining statin responses. However, there are ethnic difference in the pharmacokinetics and safety of statins and due to the different frequencies of polymorphisms and different linkage disequilibrium patterns among the ethnic groups, the genetic markers identified in genome-wide association study platforms or in candidate gene studies in one population cannot always be generalized to other populations. This review provides an overview on the pharmacogenomics of statins in Chinese population.

PMID:
23952137
DOI:
10.1586/14779072.2013.814839
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center